Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi's Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya.

Busakhala, Naftali W; Waako, Paul J; Strother, Matthew Robert; Keter, Alfred Kipyegon; Kigen, Gabriel Kimutai; Asirwa, Fredrick Chite; Loehrer, Patrick J

Busakhala, Naftali W; Waako, Paul J; Strother, Matthew Robert; Keter, Alfred Kipyegon; Kigen, Gabriel Kimutai; Asirwa, Fredrick Chite; Loehrer, Patrick J.

Afiliación

Busakhala NW; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Waako PJ; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Strother MR; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Keter AK; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Kigen GK; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Asirwa FC; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Loehrer PJ; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni

J Glob Oncol ; 4: 1-9, 2018 09.

Article en En | MEDLINE | ID: mdl-30241150

Asunto(s)

Antirretrovirales/uso terapéutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Bleomicina/uso terapéutico; Desoxicitidina/análogos & derivados; Vincristina/uso terapéutico; Adulto; Anciano; Antirretrovirales/farmacología; Protocolos de Quimioterapia Combinada Antineoplásica/farmacología; Bleomicina/farmacología; Desoxicitidina/farmacología; Desoxicitidina/uso terapéutico; Humanos; Kenia; Persona de Mediana Edad; Proyectos Piloto; Sarcoma de Kaposi; Vincristina/farmacología; Adulto Joven; Gemcitabina

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vincristina / Bleomicina / Protocolos de Quimioterapia Combinada Antineoplásica / Antirretrovirales / Desoxicitidina Tipo de estudio: Clinical_trials Límite: Adult / Aged / Humans / Middle aged País/Región como asunto: Africa Idioma: En Revista: J Glob Oncol Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google